systemic complications were noted. The right eye became better with hourly and twice a day application of topical Key words: Bevacizumab, intravitreal, lamellar cataract, steroid and cycloplegic drops respectively. At ten-month retinopathy of prematurity.
follow-up fundus of both eyes showed clear media with well-regressed ROP. Both eyes, however, were seen to Indian J Ophthalmol 2007;55:75-6 develop a lamellar cataract. As the media was clear and
Anterior segment ischemia is a rare complication of laser retinoscopy was equal in both eyes, the lamellar cataract ablation for threshold retinopathy of prematurity (ROP). This was just observed.
invariably results in phthisis. 1, 2 Recently, there has been Discussion successful treatment of iris, retinal and choroidal neovascularization with bevacizumab 3,4 (Avastin, Genentech, Anterior segment ischemia may result from thermal injury to San Francisco), a potent inhibitor of vascular endothelial the long posterior ciliary arteries in the horizontal meridian. growth factor (VEGF). Herein we report the first case of It is the most devastating complication of ablative laser for intravitreal bevacizumab for anterior segment ischemia threshold ROP, a procedure with an otherwise high benefit to following retinal ablation for aggressive posterior retinopathy risk ratio. Treatment with topical steroids and cycloplegics is of prematurity (AP-ROP).
insufficient. Vitrectomy with lensectomy and silicone oil Case Report injection may be helpful but has a high rate of re-proliferation. Bevacizumab is a full-length antibody, which binds all VEGF A male twin born at 31 weeks of gestation with birth weight isoforms and is approved for intravenous treatment of of 1170 g had bilateral AP-ROP on his first screening colorectal cancer. Our patient responded favorably to a single examination at 2.5 weeks of age. The other twin also had injection of intravitreal bevacizumab and by ten weeks all similar ocular findings but unfortunately the baby expired features of ischemia disappeared.
because of unknown cause. The twin was born with invitro Intravitreal bevacizumab seemed in this case to strikingly fertilization technique after prolonged infertility. Both eyes of the surviving twin received 3,000 spots of near-confluent infrared laser to the avascular retina. One-week postlaser the left eye developed neovascularization of iris (NVI) and mild vitreous haze. We started topical steroids and cyclopegic drops. Ten days postlaser the left eye NVI had halt the progression of anterior neovascularization, cyclitic membrane formation and hypotony that typically evolves to phthisis. Although it is conceivable that the long posterior ciliary neurovascular injury in this case was not complete and may have improved spontaneously, the prompt resolution of anterior neovascularization postinjection suggests a therapeutic effect. Although we propose that intravitreal bevacizumab may have an important role in the salvation of eyes with dire complications of ROP such as anterior segment ischemia and neovascularization and our patient did not suffer any negative effect on the growth of normal retinal vessels even at ten-month follow up, we urge caution in the generalization of these findings. Formal controlled studies with long-term follow-up are warranted to determine the potential safety and benefit of VEGF inhibitors in ROP that fails conventional therapy. 
